Anthony Marquinez, MD
Neurology · Hackensack, NJNPI 1699742551
Payments from drug & device makers
Across 183 payments — averaging $14.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$604
- UCB, Inc.$203
- Pfizer$202
- AstraZeneca$178
- AbbVie$165
- TG Therapeutics, Inc.$151
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,50795%
- Education$1465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 71 | $604 |
| UCB, Inc. | 11 | $203 |
| Pfizer | 11 | $202 |
| AstraZeneca(2 entities) | 8 | $178 |
| AbbVie | 10 | $165 |
| TG Therapeutics, Inc. | 8 | $151 |
| Argenx US, Inc. | 7 | $123 |
| Lundbeck LLC | 7 | $122 |
| SK Life Science, Inc. | 7 | $121 |
| Biogen | 5 | $119 |
| Novartis | 5 | $110 |
| Bristol Myers Squibb | 5 | $81 |
| CSL Behring | 3 | $60 |
| Amgen | 3 | $49 |
| EMD Serono, Inc. | 3 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Genentech USA, Inc. | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $29 |
| Catalyst Pharmaceuticals, Inc. | 1 | $27 |
| Grifols USA, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Neurelis, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Impel Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,653 in reported general payments places this provider in the 50th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 63 | $1,979 |
| Gabapentin | 84 | $1,538 |
| Donepezil Hcl | 124 | $1,458 |
| Memantine Hcl | 44 | $1,395 |
| Divalproex Sodium | 28 | $992 |
| AmantadineAmantadine Hcl | 21 | $977 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 38 | $628 |
| Primidone | 28 | $619 |
| Lacosamide | 12 | $491 |
| Duloxetine Hcl | 19 | $313 |
| Quetiapine Fumarate | 30 | $229 |
| Amitriptyline Hcl | 12 | $74 |
| Sumatriptan Succinate | 12 | $62 |
| Trazodone Hcl | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other neurology in Hackensack
- Mario VukicHackensack$310K
- Subasini DashHackensack$225K
- Regina KrelHackensack$199K
- Martin GizziHackensack$197K
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.